9 results on '"Barasa E"'
Search Results
2. Progress Towards Elimination of Trachoma in Kenya 2017–2020.
- Author
-
Ilako, D, Mwatha, S, Wanyama, Barasa E, Gichangi, M, Bore, J, Butcher, R, Bakhtiari, A, Boyd, S, Willis, R, Solomon, AW, Watitu, T, Chelanga, D, Nyakundi, P, Harding-Esch, EM, and Matendechero, SH
- Subjects
TRACHOMA ,DISEASE prevalence ,DRUG administration ,TROPICAL medicine ,HYGIENE - Abstract
Purpose: Trachoma is endemic in Kenya. Since baseline trachoma surveys in 2004, a concerted programme has been undertaken to reduce the prevalence of disease. Here, we report on trachoma prevalence surveys carried out between 2017 and 2020 after interventions were implemented in some areas for trachoma elimination purposes. Methods: A total of 48 cross-sectional population-based trachoma prevalence surveys were conducted in 39 evaluation units (EUs; covering 45 subcounties) of Kenya between 2017 and 2020. Thirty EUs were surveyed once and nine EUs were surveyed twice over this period. Individuals ≥ 1 year old were assessed for trachomatous inflammation–follicular (TF), trachomatous inflammation–intense (TI) and trichiasis. Data were collected on household access to water, sanitation and hygiene (WASH). Results: A total of 147,573 people were examined. At the end of 2020, in the 39 EUs surveyed, the prevalence of TF in 1–9-year-olds was ≥5% in 11 EUs and the prevalence of trichiasis unknown to the health system in individuals aged ≥15 years was ≥0.2% in 25 EUs. A small minority of households (median <50% for all indicators) had access to improved WASH facilities. Conclusion: Kenya has made excellent progress towards elimination of trachoma as a public health problem. However, there is more work to do. Between one and three rounds of antibiotic mass drug administration are required in 11 EUs. Sustained investment in surgical provision, continued TT case-finding, promotion of facial cleanliness and environmental improvement are required throughout the surveyed area. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Prevalence of Trachomatous Trichiasis in Ten Evaluation Units of Embu and Kitui Counties, Kenya.
- Author
-
Ilako, D, Barasa, E, Gichangi, M, Mwatha, S, Watitu, T, Bore, J, Rajamani, A, Butcher, R, Flueckiger, RM, Bakhtiari, A, Willis, R, Solomon, AW, Harding-Esch, EM, and Matendechero, SH
- Subjects
- *
CHLAMYDIA trachomatis , *CHLAMYDIA infections , *YOUNG women , *CLUSTER sampling , *COUNTIES , *TRACHOMA - Abstract
Late-stage blinding sequalae of trachoma such as trachomatous trichiasis (TT) typically take decades to develop and often do so in the absence of ongoing ocular Chlamydia trachomatis infection. This suggests that most TT risk accumulates in early life; as a result, population-level TT incidence and prevalence can remain high years after C. trachomatis transmission among children has decreased. In Embu and Kitui counties, Kenya, the prevalence of trachomatous inflammation – follicular is low in children. In this survey, we set out to determine the prevalence of TT in ten evaluation units (EUs) in these counties. We undertook ten cross-sectional prevalence surveys for TT. In each EU, people aged ≥15 years were selected by a two-stage cluster sampling method and examined for TT. Those with TT were asked questions on whether they had been offered management for it. Prevalence was adjusted to the underlying age and gender structure of the population. A total of 18,987 people aged ≥15 years were examined. Per EU, the median number of examined participants was 1,656 (range: 1,451 − 3,016) and median response rate was 86% (range: 81 − 95%). The prevalence of TT unknown to the health system in people aged ≥15 years was above the threshold for elimination (≥0.2%) in all ten EUs studied (range: 0.2–0.7%). TT was significantly more common in older than younger individuals and in women than in men. Provision of surgical services should be strengthened in Embu and Kitui counties of Kenya to achieve the World Health Organization threshold for eliminating TT as a public health problem. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020-21
- Author
-
Lucinde, RK, Mugo, D, Bottomley, C, Karani, A, Gardiner, E, Aziza, R, Gitonga, JN, Karanja, H, Nyagwange, J, Tuju, J, Wanjiku, P, Nzomo, E, Kamuri, E, Thuranira, K, Agunda, S, Nyutu, G, Etyang, AO, Adetifa, IMO, Kagucia, E, Uyoga, S, Otiende, M, Otieno, E, Ndwiga, L, Agoti, CN, Aman, RA, Mwangangi, M, Amoth, P, Kasera, K, Nyaguara, A, Ng'ang'a, W, Ochola, LB, Namdala, E, Gaunya, O, Okuku, R, Barasa, E, Bejon, P, Tsofa, B, Ochola-Oyier, LI, Warimwe, GM, Agweyu, A, Scott, JAG, and Gallagher, KE
- Subjects
Multidisciplinary ,SARS-CoV-2 ,COVID-19 ,Prenatal Care ,Antibodies, Viral ,Kenya ,Hospitals ,Cross-Sectional Studies ,Pregnancy ,Seroepidemiologic Studies ,Immunoglobulin G ,Spike Glycoprotein, Coronavirus ,Humans ,Female ,Pregnancy Complications, Infectious ,Referral and Consultation - Abstract
Introduction The high proportion of SARS-CoV-2 infections that have remained undetected presents a challenge to tracking the progress of the pandemic and estimating the extent of population immunity. Methods We used residual blood samples from women attending antenatal care services at three hospitals in Kenya between August 2020 and October 2021and a validated IgG ELISA for SARS-Cov-2 spike protein and adjusted the results for assay sensitivity and specificity. We fitted a two-component mixture model as an alternative to the threshold analysis to estimate of the proportion of individuals with past SARS-CoV-2 infection. Results We estimated seroprevalence in 2,981 women; 706 in Nairobi, 567 in Busia and 1,708 in Kilifi. By October 2021, 13% of participants were vaccinated (at least one dose) in Nairobi, 2% in Busia. Adjusted seroprevalence rose in all sites; from 50% (95%CI 42–58) in August 2020, to 85% (95%CI 78–92) in October 2021 in Nairobi; from 31% (95%CI 25–37) in May 2021 to 71% (95%CI 64–77) in October 2021 in Busia; and from 1% (95% CI 0–3) in September 2020 to 63% (95% CI 56–69) in October 2021 in Kilifi. Mixture modelling, suggests adjusted cross-sectional prevalence estimates are underestimates; seroprevalence in October 2021 could be 74% in Busia and 72% in Kilifi. Conclusions There has been substantial, unobserved transmission of SARS-CoV-2 in Nairobi, Busia and Kilifi Counties. Due to the length of time since the beginning of the pandemic, repeated cross-sectional surveys are now difficult to interpret without the use of models to account for antibody waning.
- Published
- 2022
5. Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya
- Author
-
Nyagwange, J, Ndwiga, L, Muteru, K, Wamae, K, Tuju, J, Testing Team, C, Kutima, B, Gitonga, J, Karanja, H, Mugo, D, Kasera, K, Amoth, P, Murunga, N, Babu, L, Otieno, E, Githinji, G, Nokes, DJ, Tsofa, B, Orindi, B, Barasa, E, Warimwe, G, Agoti, CN, Bejon, P, and Ochola-Oyier, LI
- Subjects
Medicine (miscellaneous) ,General Biochemistry, Genetics and Molecular Biology - Abstract
Background: There are limited studies in Africa describing the epidemiology, clinical characteristics and serostatus of individuals tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We tested routine samples from the Coastal part of Kenya between 17th March 2020 and 30th June 2021. Methods: SARS-CoV-2 infections identified using reverse transcription polymerase chain reaction (RT-PCR) and clinical surveillance data at the point of sample collection were used to classify as either symptomatic or asymptomatic. IgG antibodies were measured in sera samples, using a well validated in-house enzyme-linked immunosorbent assay (ELISA). Results: Mombasa accounted for 56.2% of all the 99,694 naso-pharyngeal/oro-pharyngeal swabs tested, and males constituted the majority tested (73.4%). A total of 7737 (7.7%) individuals were SARS-CoV-2 positive by RT-PCR. The majority (i.e., 92.4%) of the RT-PCR positive individuals were asymptomatic. Testing was dominated by mass screening and travellers, and even at health facility level 91.6% of tests were from individuals without symptoms. Out of the 97,124 tests from asymptomatic individuals 7,149 (7%) were positive and of the 2,568 symptomatic individuals 588 (23%) were positive. In total, 2458 serum samples were submitted with paired naso-pharyngeal/oro-pharyngeal samples and 45% of the RT-PCR positive samples and 20% of the RT-PCR negative samples were paired with positive serum samples. Symptomatic individuals had significantly higher antibody levels than asymptomatic individuals and become RT-PCR negative on repeat testing earlier than asymptomatic individuals. Conclusions: In conclusion, the majority of SARS-CoV-2 infections identified by routine testing in Coastal Kenya were asymptomatic. This reflects the testing practice of health services in Kenya, but also implies that asymptomatic infection is very common in the population. Symptomatic infection may be less common, or it may be that individuals do not present for testing when they have symptoms.
- Published
- 2022
- Full Text
- View/download PDF
6. Viewpoint: Economic evaluation of package of care interventions employing clinical guidelines
- Author
-
Barasa, E and English, M
- Abstract
Increasingly attention is shifting towards delivering essential packages of care, often based on clinical practice guidelines, as a means to improve maternal, child and newborn survival in low-income settings. Cost effectiveness analysis (CEA), allied to the evaluation of less complex intervention, has become an increasingly important tool for priority setting. Arguably such analyses should be extended to inform decisions around the deployment of more complex interventions. In the discussion, we illustrate some of the challenges facing the extension of CEA to this area. We suggest that there are both practical and methodological challenges to overcome when conducting economic evaluation for packages of care interventions that incorporate clinical guidelines. Some might be overcome by developing specific guidance on approaches, for example clarity in identifying relevant costs. Some require consensus on methods. The greatest challenge, however, lies in how to incorporate, as measures of effectiveness, process measures of service quality. Questions on which measures to use, how multiple measures might be combined, how improvements in one area might be compared with those in another and what value is associated with improvement in health worker practices are yet to be answered.
- Published
- 2011
7. Marburg virus disease outbreak in Kween District Uganda, 2017: Epidemiological and laboratory findings.
- Author
-
Luke Nyakarahuka, Trevor R Shoemaker, Stephen Balinandi, Godfrey Chemos, Benon Kwesiga, Sophia Mulei, Jackson Kyondo, Alex Tumusiime, Aaron Kofman, Ben Masiira, Shannon Whitmer, Shelley Brown, Debi Cannon, Cheng-Feng Chiang, James Graziano, Maria Morales-Betoulle, Ketan Patel, Sara Zufan, Innocent Komakech, Nasan Natseri, Philip Musobo Chepkwurui, Bernard Lubwama, Jude Okiria, Joshua Kayiwa, Innocent H Nkonwa, Patricia Eyu, Lydia Nakiire, Edward Chelangat Okarikod, Leonard Cheptoyek, Barasa Emmanuel Wangila, Michael Wanje, Patrick Tusiime, Lilian Bulage, Henry G Mwebesa, Alex R Ario, Issa Makumbi, Anne Nakinsige, Allan Muruta, Miriam Nanyunja, Jaco Homsy, Bao-Ping Zhu, Lisa Nelson, Pontiano Kaleebu, Pierre E Rollin, Stuart T Nichol, John D Klena, and Julius J Lutwama
- Subjects
Arctic medicine. Tropical medicine ,RC955-962 ,Public aspects of medicine ,RA1-1270 - Abstract
INTRODUCTION:In October 2017, a blood sample from a resident of Kween District, Eastern Uganda, tested positive for Marburg virus. Within 24 hour of confirmation, a rapid outbreak response was initiated. Here, we present results of epidemiological and laboratory investigations. METHODS:A district task force was activated consisting of specialised teams to conduct case finding, case management and isolation, contact listing and follow up, sample collection and testing, and community engagement. An ecological investigation was also carried out to identify the potential source of infection. Virus isolation and Next Generation sequencing were performed to identify the strain of Marburg virus. RESULTS:Seventy individuals (34 MVD suspected cases and 36 close contacts of confirmed cases) were epidemiologically investigated, with blood samples tested for MVD. Only four cases met the MVD case definition; one was categorized as a probable case while the other three were confirmed cases. A total of 299 contacts were identified; during follow- up, two were confirmed as MVD. Of the four confirmed and probable MVD cases, three died, yielding a case fatality rate of 75%. All four cases belonged to a single family and 50% (2/4) of the MVD cases were female. All confirmed cases had clinical symptoms of fever, vomiting, abdominal pain and bleeding from body orifices. Viral sequences indicated that the Marburg virus strain responsible for this outbreak was closely related to virus strains previously shown to be circulating in Uganda. CONCLUSION:This outbreak of MVD occurred as a family cluster with no additional transmission outside of the four related cases. Rapid case detection, prompt laboratory testing at the Uganda National VHF Reference Laboratory and presence of pre-trained, well-prepared national and district rapid response teams facilitated the containment and control of this outbreak within one month, preventing nationwide and global transmission of the disease.
- Published
- 2019
- Full Text
- View/download PDF
8. Poly(phenylacetylene)s with Pendant Sulfonamide Receptors for Anion Detection.
- Author
-
SAKAI, R., BARASA, E. B., SAKAI, N., SATO, S.-I., SATOH, T., and KAKUCHI, T.
- Published
- 2013
- Full Text
- View/download PDF
9. HTA16 Eliciting Preferences for Health Technology Assessment Criteria Using Analytic Hierarchy Process and Discrete Choice Experiment in Kenya.
- Author
-
Obadha, M., Mumbi, A., Njuguna, R.G., Orangi, S., Nguhiu, P., Ngaiza, G., Omollo, H., Njeru, N., and Barasa, E.
- Subjects
- *
TECHNOLOGY assessment , *ANALYTIC hierarchy process , *DISCRETE choice models - Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.